DK1592439T3 - Process for preparing an albumin solution - Google Patents

Process for preparing an albumin solution

Info

Publication number
DK1592439T3
DK1592439T3 DK04710818T DK04710818T DK1592439T3 DK 1592439 T3 DK1592439 T3 DK 1592439T3 DK 04710818 T DK04710818 T DK 04710818T DK 04710818 T DK04710818 T DK 04710818T DK 1592439 T3 DK1592439 T3 DK 1592439T3
Authority
DK
Denmark
Prior art keywords
albumin solution
albumin
groups
virus
reagents
Prior art date
Application number
DK04710818T
Other languages
Danish (da)
Inventor
Werner Gehringer
Katharina Pock
Juergen Roemisch
Tor-Einar Svae
Christoph Kannicht
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Application granted granted Critical
Publication of DK1592439T3 publication Critical patent/DK1592439T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a therapeutically usable virus-inactivated albumin and a method for producing a therapeutically usable virus-inactivated albumin, which is characterized by a combination of the following steps: (a) a first aqueous albumin solution is subjected to a virus inactivation treatment according to the SD method by contacting said aqueous albumin solution with SD reagents at a temperature of less than 45 DEG C; (b) the SD reagents are at least essentially removed by means of oil extraction and subsequent hydrophobic interaction chromatography, a hydrophobic matrix, especially a matrix to which optional hydrophobic groups can be bonded, being used for the chromatography process provided that said groups are aliphatic groups wherein C > 24, and a second albumin solution is obtained to which (c) one or several stabilizers from the group comprising sugar, amino acids, and sugar alcohols is/are optionally added provided that no indole stabilizer and no C6-C10 fatty acid are used as stabilizers; whereupon (d) the second albumin solution, to which stabilizer has been optionally added, is finished and sterilized by filtration and optionally filled into final containers.
DK04710818T 2003-02-13 2004-02-13 Process for preparing an albumin solution DK1592439T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT2182003 2003-02-13
PCT/EP2004/001397 WO2004071524A1 (en) 2003-02-13 2004-02-13 Albumin solution and method for the production thereof

Publications (1)

Publication Number Publication Date
DK1592439T3 true DK1592439T3 (en) 2007-09-10

Family

ID=32854882

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04710818T DK1592439T3 (en) 2003-02-13 2004-02-13 Process for preparing an albumin solution

Country Status (22)

Country Link
EP (1) EP1592439B1 (en)
JP (1) JP2006517938A (en)
KR (1) KR20050103292A (en)
CN (1) CN100384471C (en)
AT (1) ATE362376T1 (en)
AU (1) AU2004212324B2 (en)
BR (1) BRPI0407458A (en)
CA (1) CA2514163A1 (en)
CY (1) CY1106793T1 (en)
DE (1) DE502004003834D1 (en)
DK (1) DK1592439T3 (en)
ES (1) ES2285427T3 (en)
IL (1) IL169828A0 (en)
MX (1) MXPA05008276A (en)
NO (1) NO20053677L (en)
PL (1) PL376644A1 (en)
PT (1) PT1592439E (en)
RS (1) RS50891B (en)
RU (1) RU2305556C2 (en)
UA (1) UA80469C2 (en)
WO (1) WO2004071524A1 (en)
ZA (1) ZA200506452B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005023155A1 (en) * 2005-05-13 2006-11-16 Albutec Gmbh albumin solution
CA2634329A1 (en) * 2005-12-22 2007-07-19 Csl Behring Gmbh Octanoate-reduced human albumin
ES2332846B1 (en) 2007-10-26 2010-07-08 Grifols, S.A. USE OF THERAPEUTIC HUMAN ALBUMIN FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF PATIENTS AFFECTED BY COGNITIVE DISORDERS.
ES2294976B1 (en) 2007-11-12 2008-12-16 Grifols, S.A. "HIGH EFFECTIVE HUMAN ALBUMIN OBTAINING PROCEDURE FOR USE IN DETOXIFICATION THERAPY".
EP2382993A1 (en) 2010-04-19 2011-11-02 KTB Tumorforschungsgesellschaft mbH Combination of drugs with protein-binding prodrugs
CN111195351A (en) * 2020-01-20 2020-05-26 华兰生物工程重庆有限公司 Preparation method of 5% low-concentration human serum albumin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0669961B2 (en) * 1984-09-25 1994-09-07 株式会社ミドリ十字 Immunoglobulin heat treatment method
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US5250662A (en) * 1989-10-05 1993-10-05 Alpha Therapeutic Corporation Albumin purification
DE19729778A1 (en) * 1997-07-11 1999-01-21 Blutspendedienst Der Drk Lande Process for the preparation of virus-inactivated biological fluids
US5919907A (en) * 1997-12-22 1999-07-06 Shanbrom Technologies Llc Preparation and utilization of a novel sterile albumin
IL136552A (en) * 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration

Also Published As

Publication number Publication date
RU2005128507A (en) 2006-01-20
CY1106793T1 (en) 2012-05-23
EP1592439B1 (en) 2007-05-16
PT1592439E (en) 2007-06-22
AU2004212324A1 (en) 2004-08-26
CN1798573A (en) 2006-07-05
UA80469C2 (en) 2007-09-25
JP2006517938A (en) 2006-08-03
PL376644A1 (en) 2006-01-09
AU2004212324B2 (en) 2009-05-07
CN100384471C (en) 2008-04-30
WO2004071524A1 (en) 2004-08-26
MXPA05008276A (en) 2006-03-21
EP1592439A1 (en) 2005-11-09
IL169828A0 (en) 2011-08-01
RS20050624A (en) 2007-06-04
DE502004003834D1 (en) 2007-06-28
BRPI0407458A (en) 2006-01-31
ATE362376T1 (en) 2007-06-15
RU2305556C2 (en) 2007-09-10
KR20050103292A (en) 2005-10-28
NO20053677D0 (en) 2005-07-29
NO20053677L (en) 2005-10-31
CA2514163A1 (en) 2004-08-26
RS50891B (en) 2010-08-31
ES2285427T3 (en) 2007-11-16
ZA200506452B (en) 2007-01-31

Similar Documents

Publication Publication Date Title
NO20053677D0 (en) Album release and method of preparation thereof
DE69628148D1 (en) METHOD FOR PRODUCING A PROTEIN
MA32510B1 (en) Process for the extraction of fatty acids from algal biomass
DE60235810D1 (en) METHOD OF PREPARING L-AMINO ACIDS BY ENTEROBACTERIACEAE STRAINS WITH INCREASED EXPRESSION OF THE FBA GENE
ATE466075T1 (en) NEW DEHYDROGENASES, THEIR DERIVATIVES AND A METHOD FOR PRODUCING OPTICALLY ACTIVE ALKANOLS
DE60031208D1 (en) Process for the preparation of microbeads containing fat-soluble substances
EA201001444A1 (en) Synthesis of esters or adipate esters
AR048026A1 (en) PROCEDURES FOR THE IDENTIFICATION OF PROTEINS WITH ENZYMATIC ACTIVITY FOSFORILADORA DE ALMIDON
DK1794A (en) Method of producing sterile milk by dynamic microfiltration
ATE235475T1 (en) INTERMEDIATE AND METHOD FOR PRODUCING OPTICALLY ACTIVE OCTANIC ACID DERIVATIVES
ATE475646T1 (en) METHOD FOR PRODUCING PYRROLIDONES
WO2004045540A3 (en) Method for continuous, automated blending of solutions from acids and bases
ATE376989T1 (en) METHOD FOR PRODUCING XYLYLENEDIAMINE (XDA)
ATE221323T1 (en) METHOD FOR PRODUCING A PROTEIN Isolate FROM A SUBSTANCE CONTAINING PROTEIN
NO20055948L (en) Purification of HER-2 variants
KR101862332B1 (en) Process for manufacturing influenza whole virus vaccine
DE502006005580D1 (en) PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE 3-PHENYLPROPIONIC ACID DERIVATIVES AND FOLLOW-UP PRODUCTS THEREOF
CN102690798A (en) Method for extracting TAQ enzyme for amplification
ATE497498T1 (en) METHOD FOR PRODUCING OXIRANECARBONY ACIDS AND DERIVATIVES THEREOF
KR20060132590A (en) A process for the preparation and purification of recombinant proteins
SU1085974A1 (en) Process for preparing dl-glutamic acid
EP0238986A3 (en) Process for the production of a preparation of blood coagulation factor viii in a concentrated form
DE59611145D1 (en) METHOD FOR THE CONTINUOUS PRODUCTION OF BASIC, CYCLIC, OPTICALLY ACTIVE Alpha-AMINO ACIDS
TH35753C3 (en) Enhanced immunogens For inactivated vaccines to fight infectious diseases That is caused by the group of J.Panes Enzephalitis virus and the method for producing it
UA42436A (en) method for producing the bovine serum albumin (BSA)